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ABSTRACT
Background. Neonatal hyperbilirubinemia (HB) may cause severe neurological
damage, but serious consequences are effectively controlled by phototherapy and
blood exchange transfusion. HB is still a serious health problem in economically
compromisedpartsoftheworld.Thelongtermoutcomehasbeenregardedfavorable
based onepidemiological data, buthas not beenconfirmed in prospectivefollow-up
studiesextendingtoadulthood.
Methods.WestudiedthelongtermconsequencesofHBinaprospectivebirthcohort
of 128 HB cases and 82 controls. The cases are part of a neonatal at-risk cohort
(n = 1196) that has been followed up to 30 years of age. HB cases were newborns
≥2500gbirthweightand≥37weeksofgestationwhohadbilirubinconcentrations
>340µmol/lorrequiredbloodexchangetransfusion.SubjectswithHBweredivided
into subgroups based on the presence (affected HB) or absence (unaffected HB) of
diagnosed neurobehavioral disorders in childhood, and compared with healthy
controls. Subjects were seen at discharge, 5, 9 and 16 years of life and parent’s and
teacher’s assessments were recorded. At 30 years they filled a questionnaire about
academic and occupational achievement, life satisfaction, somatic and psychiatric
symptoms including a ADHD self-rating score. Cognitive functioning was tested
usingITPA,WISC,andreadingandwritingtestsat9yearsoflife.
Results.Comparedtocontrols,theoddsforachildwithHBhavingneurobehavioral
symptoms at 9 years was elevated (OR = 4.68). Forty-five per cent of the HB group
were affected by cognitive abnormalities in childhood and continued to experience
problems in adulthood. This was apparent in academic achievement (p < 0.0001)
and the ability to complete secondary (p < 0.0001) and tertiary (p < 0.004) edu-
cation. Also, the subgroup of affected HB reported persisting cognitive complaints
e.g., problems with reading, writing and mathematics. Childhood symptoms of hy-
peractivity/impulsivity(p < 0.0001)andinattention(p < 0.02)weremorecommon
in HB groups, but in adulthood the symptoms were equal. The affected HB had
lowerscoresinparametersreflectinglifesatisfaction,lesscontrolleddrinking,butnot
increasedsubstanceabuse.
Discussion. Our results indicate that neonatal HB has negative consequences in
adult age. A prospectively collected cohort with strict inclusion criteria enables
to control most of the bias factors involved with retrospective data. The control
and HB groups were remarkably similar at birth in terms of medical data, and the
How to cite this article Hokkanen et al. (2014), Adult neurobehavioral outcome of hyperbilirubinemia in full term neonates—a 30 year
prospective follow-up study. PeerJ2:e294; DOI10.7717/peerj.294growth environment of the children, as well as the parents’ social groups, education,
size of family, type of housing at birth and at 9 years of age. Our findings bear
resemblance to disorders of the fronto-striatal network, and also symptoms of the
ADHD spectrum were frequent in the HB group suggesting a link of HB to other
neurodevelopmentaldisorders.
Subjects Cognitive Disorders, Neurology, Pediatrics, Psychiatry and Psychology
Keywords Hyperbilirubinemia, Outcome, Neurobehavioral, Neonatal, Adulthood, Intelligence,
Cohort, Prospective
INTRODUCTION
Neonatal hyperbilirubinemia (HB) is a well-recognized risk for severe neurological
disability and death (Ip et al., 2004). While it is at present reasonably well controlled
in the developed countries, it is still a concern in economically compromised areas
(Sgro, Campbell & Shah, 2006; Kaplan, Bromiker & Hammerman, 2011). The pathogenesis
of encephalopathy by unconjugated bilirubin is poorly understood but neuronal damage
may be linked to oxidative stress and a disruption of the blood–brain barrier (Palmela et
al., 2011). Kernicterus refers to the severe neurodevelopmental consequences, but more
subtle forms of bilirubin encephalopathy also exist (Shapiro, 2003; Johnson & Bhutani,
2011). The type and severity of the effects of HB have mostly been studied in relatively
shortfollow-upstudiesranginguptoschoolage,wheremildtomoderateneonatalHBhas
appeared to be relatively, if not totally, benign (Culley et al., 1970; Newman & Klebanoff,
2002; Ip et al., 2004; Gamaleldin et al., 2011). There is still controversy however on the
risks for neurodevelopmental disorders in later childhood (Shapiro, 2003; Kuzniewicz &
Newman,2009;Johnson&Bhutani,2011;Koziol,Budding&Chidekel,2013).Todate,there
are very few studies on neonatal hyperbilirubinemia followed up to early adulthood,
and none beyond 20 years. The existing ones are based on retrospective analysis of
birth data during military drafting of conscripts (Nilsen et al., 1984; Seidman et al., 1991;
Ebbesenetal.,2010).
In a Norwegian study reporting results of 39 male conscripts at 18 years of age, the
mean intelligence scores were comparable to the total conscript cohort, but seven subjects
with a more severe hyperbilirubinemia had significantly lower scores than the national
average (Nilsen et al., 1984). A study from Israel with a much larger sample (n = 1948)
foundnolinearassociationbetweenneonatalbilirubinlevelsandintelligencetestscoresor
schoolachievementat17yearsofage,buttheriskforlowintelligencetestscoreswashigher
among full term males (but not females) with serum bilirubin levels above 342 µmol/l
(Seidman et al., 1991). The most recent study was from Denmark, where no association
between higher bilirubin levels and the risk of obtaining a neuropsychiatric diagnosis, or
scoringlowerinthecognitivetestusedinthedraftingwasseeninmaleswithamedianage
of 18.8 years (Ebbesen et al., 2010). There was however a larger proportion of men found
unfit for military service in the HB group. Also, only 25 subjects (6% of all hyperbilirubin
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valuethathaspreviouslybeenregardedsignificant.
These studies have mainly relied on IQ data and only offer limited outcome informa-
tion.Intelligencescoresareofteninsensitivetoexecutivedysfunction,learningdeficitsand
affective disorders (Johnson & Bhutani, 2011). An association between neonatal jaundice
and neurodevelopmental syndromes, e.g., ADHD has been suggested (Jangaard et al.,
2008) but not proven (Kuzniewicz, Escobar & Newman, 2009). Also a link to autism
and other disorders of psychological development has been presented in HB (Jangaard
et al., 2008; Maimburg et al., 2010). In a national cohort from Denmark, full-term
children exposed to jaundice as neonates had 56% to 88% greater risks of psychological
developmentdisorders,comparedwithchildrennotexposedtojaundice(Maimburgetal.,
2010).TheconclusionofHBbeingofbenignnaturebasedonintelligencetestfindingsmay
therefore be inaccurate. Very little is known about the vocational and social outcome of
hyperbilirubinemiainadults.
We report here the 30 year results of a prospective follow-up study on a birth cohort
of full term and normal weight newborns with hyperbilirubinemia (HB > 340 µmol/l)
as the only birth risk factor whose adult outcome is compared to healthy, typically
developed controls similarly followed-up. Our aim was to study if the cognitive and
behavioral problems discovered in childhood continue in adulthood, and if they affect
theeducational,occupational,andsocialfunctioningaswellashealthandwellbeingofthe
adultsubjects.
MATERIAL & METHODS
Participants
The birth risk cohort originates from a single maternity hospital in Helsinki, Finland.
During the recruitment period 1971–74, there were 22,359 consecutive births in this
hospital,outofwhich1196(5.4%)neonateshadatleastonepredefinedrisk:APGARscore
lower than 7 at 5 or 15 min (n = 372), birth weight under 2000 grams (n = 317), jaundice
withbilirubin> 340µmol/l(n = 368),severerespiratorydifficultiesnecessitatingexternal
ventilation (n = 161), neurological symptoms (n = 195), maternal diabetes (n = 95),
infanthypoglycemia(n = 104),andsevereinfection(n = 36);19%hadmorethanonerisk
factor(Michelssonetal.,1978).
For the present study only full term neonates with hyperbilirubinemia were included.
For inclusion, at least two serum bilirubin values of 340 µmol/l (20 mg/100 ml) or
more were required. Children who had received blood exchange transfusion because of
rapidlyincreasingserumbilirubinvalueswerealsoincluded.Thosewhodiedduringearly
childhood and those with severe disabilities (incl. kernicterus) were excluded from follow
up (Michelsson, Donner & Lindahl, 1988). Additional exclusion criteria for the present
study included gestational age below 37 weeks, or birth weight below 2500 g. There were
238 HB cases fulfilling these inclusion and exclusion criteria. All subjects were Caucasian
andthefamiliesspokeFinnish.
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hospitalduringthestudyperiod,attendedthesameschools,andwerefreeofanyperinatal
risk factors. For the present study those with gestational age at or above 37 weeks, birth
weightatorabove2500gandfullassessmentinformationfrom9yearsofageareincluded
(n = 145).
Ethical review has been conducted over the course of the longitudinal study, and the
latest approval was obtained from the Ethical Review Board of the Helsinki and Uusimaa
hospital district in May 2013 (number 147/13/3/00/2013). All participants gave their
writtenconsenttothestudy.
Methods and procedures
The family’s social and economic status, maternal risk factors, genetic traits, medical data
aboutdeliveryanddeliverycomplicationswasrecordedprospectively.Thesocio-economic
status was defined as the father’s occupational level (1 to 5, 1 being the highest category).
Psychosocial distress score was formed to include poor housing conditions, divorces,
relocations, alcohol abuse, unemployment, family conflicts, domestic violence, imprison-
ment, severe diseases or mental problems in family. Body-mass index was calculated as an
indicatorofthegeneralhealthanddevelopmentofthechild.
The cognitive and behavioral problems in childhood were assessed when the children
were 5 and 9 years of age. This coincides with periods before and after entering school (at
the age of 7 in Finland). The assessment methods have been described in detail elsewhere
(Hokkanen, Launes & Michelsson, 2013). To summarize, a structured neurological
assessmentwascarriedat5andat9yearsofageoutusingtheNeurodevelopmentalScreen
developed by Michelsson et al. (Michelsson, Ylinen & Donner, 1981; Lindahl, Michelsson
& Donner, 1988). The method is a modification of the test of Bax & Whitmore (1973)
that examines visual acuity, squint, gross motor performance, fine motor performance,
co-ordination and balance, involuntary movements when standing, upper motor neuron
disturbances, articulation, language skills, perception, concentration and behavior.
Other standardized tests and measures used at 5 and/or 9 years of age include the Test
of Motor Impairment (Stott, Moyes & Henderson, 1972), the Dubowitz Intellectual
developmentscreeningtest(Dubowitz,Leibowitz&Goldberg,1977)measuringperceptual
and numerical skills, The Illinois Test of Psycholinguistic Abilities (Kirk, McCarthy &
Kirk, 1968), The Draw-a-person test (Goodenough, 1926), the Frostig Developmental Test
of Visual Perception (Frostig, Lefever & Whittlesey, 1966), Reading and spelling tests for
Finnish children (Ruoppila, Roman & Vasti, 1968; Ruoppila, Roman & Vasti, 1969) and
subtestsfromtheWechslerIntelligenceScaleforChildren(WISC,Wechsler,1949).
A questionnaire was filled out by parents both at ages 5 and 9 regarding the parents’
work situation, existing developmental problems or disabilities within the family,
the child’s home environment, development and skill acquisition, illnesses, school
achievement and problem behaviors. The existing problems within the family that were
probed were: delayed speech, delayed motor skills, clumsiness, reading and spelling
difficulties, other school problems, inattention or short temperedness, squint, impaired
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in other family members. In addition, the questionnaire at 5 years included 28 questions
regarding the activity level, motor skills, communication and emotional affectivity of the
child rated in a three point scale. At 9 years of age a questionnaire was also sent to the
teachers concerning school achievement and the need of remedial teaching or a special
class. Additionally, the teacher was asked to perform an evaluation of the pupil’s behavior
and personality in class using 24 adjective pairs (e.g., observant—day dreaming) with a
five point rating between the extremes, as well as five open-ended questions for additional
information.
Based on the comprehensive assessments with measures described above, the children
were classified into either having or not having different developmental disorders. The
decisions were agreed upon at a clinical case conference between a pediatrician, child
neurologist, a psychologist, and a speech therapist, who had performed the assessments.
The results of these 5 and 9 year assessments have been published previously (Lindahl
& Michelsson, 1986; Lindahl & Michelsson, 1987; Lindahl, Michelsson & Donner, 1988;
Michelsson, Ylinen & Donner, 1981; Michelsson, Donner & Lindahl, 1988; Michelsson &
Lindahl, 1984; Michelsson & Lindahl, 1987; Michelsson et al., 1988; Michelsson & Lindahl,
1993; Michelsson & Noronen, 1983). The diagnostic classification in the HB group were as
follows: 21% had minimal brain dysfunction (MBD)—a diagnosis in use at the beginning
of the cohort study defined as three or more concomitant deficits—30% had dyslexia,
27% perceptual disabilities (auditory, visual or undefined), 27% had motor impairment,
15% hyperactivity and attention deficit, 11% significant psychiatric and psychosomatic
symptoms, 9% had neurological signs, and 5% had speech and language abnormalities
(not including dyslalia only). For the purposes of the present study, a combined score of
all the developmental findings was constructed and those with a score of 1 or above were
considered to be affected with at least one of the diagnoses. To analyze the persistence of
symptoms discovered in childhood, the subjects were divided into two groups (affected
andunaffected),basedonthisclassification.
Long term outcome at the age of 30 years was assessed with an extensive questionnaire
prepared for the purposes of this study. Educational outcome was measured by questions
regarding school achievement (graduation from first-level obligatory school, the need
for remedial teaching, the final school grades earned, and the highest degree completed
in secondary or tertiary education). Occupational achievement was measured with a
question about the type of present employment (full-time, part-time, student, maternity
leave, unemployed). Social functioning was assessed with a combined score measuring
social satisfaction (three items) and social contacts (two items), higher value indicating
moredissatisfaction.Lifesatisfaction,satisfactionwithsocialrelationshipsandsatisfaction
with social support received were measured with a 5 point scale (from very satisfied to
very unsatisfied) and the social contact items included reported difficulty in making
friends or maintaining social relationships (yes/no). General health was measured with
a combined score of subjective health (rated with a five-point scale from very good to very
poor), the number of doctors’ appointments (four-point scale), the use of medication for
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The incidence of past traumas, fractures and concussions was also noted. Substance use
(illicitdrugs,alcoholconsumptionfrequency,alcoholrelatedproblems)werealsoincluded
in the questionnaire as indicators of health and well-being. In addition to categorical
variables, an alcohol consumption score was constructed by combining items of regularly
drinking more than once a month (dichotomized from a six-point scale from never to
daily), excessive use expressed by family members (yes/no), excessive use estimated by self
(yes/no) and reported incidences of driving while intoxicated (yes/no). The psychiatric
status was measured with a combined score of reported psychiatric problems (presence
or absence of depression, anxiety disorder, panic disorder, obsessive-compulsive traits,
manic-depression, or sleep disorders), and the use of prescribed sedatives or hypnotics.
The behavioural outcome was measured with the ADHD Current Symptoms Scale as
well as the ADHD Childhood Symptoms Scale where each of the 18 DSM-IV (American
Psychiatric Association, 1994) diagnostic symptom criteria is scored from 0 to 3 depending
on the severity of symptoms (Barkley & Murphy, 1998). Cognitive outcome was measured
with ongoing cognitive complaints (presence or absence of persisting subjective learning
difficulties, writing difficulties, reading difficulties, perceptual problems, mathematical
problems,speechproblems,motor/dexterityproblems).
Of the cases fulfilling the criteria of the present study, 128 HB cases (54%) and 82
controls(57%)returnedanadequatelycompletedquestionnaireattheageof30years.See
Fig. 1 for the complete flow chart. We analyzed the possible attrition bias caused by the
54% compliance in the HB group by comparing the responders and the non-responders
(data not shown). At birth, there was no difference between the groups in the parity,
the percentage of small-for-date, apgar points, gestational weeks, birth weight, head
circumference, gender ratio, mother’s smoking habits during pregnancy, or the family
socio-economic status. The developmental classification score at the age of 9 years was
similarinbothgroups.
Statistical analysis
Statistical analysis was performed using the STATISTICA analysis software (StatSoft, Inc.,
2013). For continuous outcome variables, a multiple analysis of variance (MANOVA)
was used in three separate models that included variables of for birth data, cognitive tests
at 9 years of age, and ADHD symptom scores at 30 years. Missing data was replaced by
mean values of relevant groups. Differences between three groups were further tested by
univariate analysis of variance (ANOVA) and pair-wise comparisons. Due to multiple
comparisons, we used the Bonferroni method post-hoc test because of the conservative
estimates it produces. The Kruskall–Wallis nonparametric analysis of variance was used
for ordinal variables or when the distribution was skewed. For testing significance of two
independent variables, the Mann–Whitney-U or the Kolmogorov–Smirnov two sample
testswereused.FrequencieswerecalculatedfromcontingencytablesandFisher’sexacttest
wasusedtotestthesignificancein2×2tables.
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 6/20Figure1 Flowchartofthebirthriskcohortsubjectsandcontrols.
RESULTS AND DISCUSSION
There were 57 HB cases with at least one neurobehavioral disability used for classification
at 9 years of life (the affected-HB group) and 71 with no disabilities (the unaffected-HB
group). The controls were similarly classified into unaffected (n = 70) and affected
(n = 12) groups. The odds ratio was calculated as OR = 4.68 (95% confidence interval
2.21–10.11) for a subject with HB of belonging in the affected group as compared to
controls.
The result indicates that the odds for a subject with neonatal HB being in the affected
group was nearly five-fold compared to the controls. As ADHD, dyslexia and other
developmental disabilities are each found in about 5%–10% of the general population
(Shaywitz&Shaywitz,2005;Polanczyketal.,2007;Willcuttetal.,2010),findingindividuals
affected with, e.g., reading or writing impairment, motor difficulties, and attentional
problemsinourcontrolgroupaswellwasexpected.HBhowevergreatlyincreasesthisrisk.
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significances for differences between the three groups in univariate comparisons are also given.
Affected-HB
n = 57
Unaffected-HB
n = 71
Controls
n = 70
Mean
(95%CI)
Mean
(95%CI)
Mean
(95%CI)
Univariatetestacross
thethreegroups
Gestational age (weeks) 39.5
(39.1–39.8)
39.3
(38.9–39.6)
39.8
(39.5–40.2)
ns
Birth weight (g) 3505
(3376–3633)
3469
(3354–3585)
3538
(3428–3649)
ns
Head circumference (cm) 34.6
(34.2–34.9)
35.0
(34.7–35.3)
35.0
(34.7–35.4)
ns
Apgar 1 min 8.6
(8.4–8.8)
8.5
(8.3–8.8)
8.9
(8.7–9.2)
ns
Apgar 5 min 9.8
(9.7–10.0)
9.9
(9.7–10.0)
9.6
(9.4–9.7)
p < 0.002
Apgar 15 min 9.9
(9.9–10.1)
9.9
(9.8–10.0)
10.0
(9.9–10.1)
ns
Maternal age (years) 25.4
(24.3–26.5)
26.0
(25.0–27.0)
26.8
(25.4–28.1)
ns
<300 2 <300 1
300–339 5 300–339 3
340–399 29 340–399 32
400–449 14 400–449 23
Peak bilirubin value,
distribution of cases
>450 3 >450 3
Gender m/f 35/22 39/32 30/40 ns
Notes.
CI, Confidence Interval of the mean.
To study if the neurobehavioral difficulties of childhood improve or disappear in
adulthood,wecontinuedtoexaminetheaffectedandunaffectedsubgroupseparately.The
subgroups were based on categories that had been formed prospectively, independently
from the present study. Because the aim was to compare the HB group with typically
developedhealthysubjects,controlsaffectedwithdevelopmentaldisabilitieswereexcluded
fromfurtheranalyses.Therationalewasthatacontrolgroupcontainingbothaffectedand
unaffected individuals would have created a bias in favor of unaffected HB and in disfavor
ofaffected-HBcases,obscuringthepotentialdifferences.
The management of neonatal hyperbilirubinemia
Table 1 shows the perinatal background data in the three groups. A statistically significant
difference was found in MANOVA for the continuous variables (Wilks’ Lambda
p < 0.0001) but in univariate ANOVAs only the 5 min apgar differed between the groups,
with the control group actually being the lowest. There was a slight but statistically not
significant over representation of girls in the control group (57%) and boys in the affected
(61%)andunaffected(55%)HBgroup.
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 8/20No difference between the affected-HB and unaffected HB-groups was found in parity,
the percentage of small-for-date, mother’s smoking habits during pregnancy, maternal
diabetes,thenumberofX-rayinvestigationsduringpregnancy,pastmiscarriages,maternal
blood pressure, mother’s weight gain during pregnancy, glycosuria, toxemia, mother’s
marital status or the hereditary traits (diabetes, neurological, sensory deficits). Among
all cases with HB, 54 received phototherapy and 79 had blood exchange transfusions
(in six cases more than one transfusion). The number of treatments was equal in the
affected-HB group (46 treated, 11 non-treated) and the unaffected-HB HB group (55
treated, 16 non-treated). Neither were there any significant differences in the start time,
duration of HB or the peak bilirubin value. ABO blood group incompatibility was present
in 40 cases and Rh incompatibility in one. The treated and non-treated HB subjects were
equalintermsofcognitivetesting,schoolperformance,andotherassessmentsat9yearsof
ageindicatingthattreatmentdecisionsdidnotexplainthemeasuredoutcomedifferences.
Medical events and development at birth, and 9 years of life
There were no differences in the children’s hospitalizations, traumas, or other somatic
complaints and diseases in follow-up. The body-mass-index BMI of the child was similar
in the three groups at age 9 years (see Table 2). The groups did not differ in the amount of
reported past developmental problems within the family (44% in the affected-HB, 28% in
theunaffected-HBand34%inthecontrols).
The family’s socio-economic status was the highest and the social distress scores the
lowest in the unaffected HB group differentiating it from the affected HB group but not
from the control group in pair-wise comparisons. The affected-HB group did not differ
from the controls. The significance levels were low and considering the multiple tests
performed,thefindingsarenotconsideredmeaningful.
The performance of the groups in the Illinois Test of Psycholinguistic Abilities (ITPA),
the Reading and spelling tests as well as the Wechsler Intelligence Scale for Children
(WISC) performed at the age of 9 years is presented in Table 2 demonstrating significant
differences between the three groups (MANOVA Wilks’ lambda p < 0.0001). In pair-wise
comparisons the affected-HB group differed from the controls in all tests conducted; the
unaffected-HB group differed from the controls only in spelling test (p < 0.003). The
frequencyofremedialinstructioninpreschoolandschooluntilnineyearsofagehadbeen
86%inaffected-HB,44%inunaffected-HB,and28%inthecontrolgroups(p < 0.0001).
Theresultsshowthatdespitesimilarmedicalhistoryandgrowthpattern,manychildren
in the HB group managed less well in the psychological tests than the control group.
This is in line with a previous cross-sectional study of this cohort (Michelsson, Donner
& Lindahl, 1988). In that study, where cases under 2500 g and 35–36 weeks at birth were
also included, half of the HB group presented with writing difficulties at the age of 9 years
(Helenius,1987).Theyalsohadmoreproblemsatschool,hadlowergrades,andmoreoften
attended special classes (Michelsson, Donner & Lindahl, 1988). In the present study, where
the pre-term cases were excluded, cognitive tests showed the same result. The mean IQs
were above average in all groups but as the controls performed at a high average range,
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aswellasthehealthycontrolsat9yearsofage. The significance for differences between the three groups in univariate comparisons is also given.
Affected-HB
n = 57
Unaffected-HB
n = 71
Controls
n = 70
Mean
(95%CI)
Mean
(95%CI)
Mean
(95%CI)
Univariatetestacross
thethreegroups
Cognitivefunctioning
WISC VIQ 104.8
(102.0–107.6)
119.2
(116.6–121.7)
120.0
(117.4–122.5)
p < 0.0001
WISC PIQ 109.1
(106.1–112.2)
118.2
(115.5–121.0)
122.4
(119.7–125.2)
p < 0.0001
WISC FSIQ 107.4
(104.6–110.3)
121.0
(118.4–123.5)
123.3
(120.8–125.9)
p < 0.0001
ITPA total 33.8
(33.0–34.7)
37.7
(36.9–38.4)
37.2
(36.5–38.0)
p < 0.0001
Reading test 8.3
(8.1–8.6)
8.8
(8.6–9.0)
8.8
(8.6–9.0)
p < 0.003
Spelling test 7.0
(6.8–7.3)
7.9
(7.6–8.2)
8.5
(8.3–8.8)
p < 0.0001
Healthandfamilysituation
BMI 29.8
(28.5–31.1)
31.6
(30.5–32.7)
31.5
(30.4–32.6)
ns
Social distress score 4.3
(3.4–5.1)
2.7
(2.0–3.4)
3.1
(2.4–3.8)
p < 0.02
Socio-economic status 2.4
(2.1–2.7)
1.9 (1.6–2.1) 2.0
(1.8–2.3)
p < 0.04
Notes.
WISC,WechslerIntelligenceScaleforChildren;VIQ,VerbalIntelligenceQuotient;PIQ,PerformanceIntelligenceQuotient;FSIQ,FullScaleIntelligenceQuotient;ITPA,
Illinois Test of Psycholinguistic Abilities; BMI, Body Mass Index; CI, Confidence Interval of the mean.
possibly due to somewhat outdated norms and the so-called Flynn effect (Flynn, 1987),
the differences were significant. As expected based on the classification performed, the
affected-HB children also needed more special education and help in school. Thus, the
negativeeffectofHBtocognitionwasnotcausedbytheborderlinecasesoflowweightand
gestationalage.
In contrast to our observations, studies reporting childhood outcomes of HB have
mostly found no significant consequences (Culley et al., 1970; Newman & Klebanoff,
2002; Ip et al., 2004; Gamaleldin et al., 2011). In our cohort 55% of the HB subjects
belonged to the unaffected group and these subjects were comparable to controls in
most variables studied, supporting the general view. However, a smaller percentage was
affected,resemblingthecohortinDenmark(Maimburgetal.,2010),emphasizingtheneed
to identify separate subgroups. Conflicting findings may also depend on the different ages
of children studied. An important factor influencing the clinical picture is the maturation
of frontal cortices, which is not complete until after adolescence, perhaps in the ages
between15and20yearsofage(Paus,2005).Therateofthisdevelopmentispoorlyknown,
and maturation rates may differ between genders, which should be considered when
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IQ scores is also unclear (Burgaleta et al., 2014). A third potential factor is the Hawthorne
effect: very active treatment is likely to be given in centers where also research is done,
whichmayskewresultsinthedirectionoflessseriousconsequences.
Academic and occupational achievement reported at 30 years of
age
All but 2 subjects in all groups combined had graduated from first level education (the
first obligatory nine years). However, 11% of the affected-HB subjects reported having
required remedial teaching or a special class during those nine school years, in contrast
to only one child in the control group and none in the unaffected-HB group (p < 0.004).
The proportion of subjects who had received the diploma at the end of the secondary
education (after 12 years of school) was 30% in the affected-HB group, 70% in the
unaffected-HB and 75% in the control group (p < 0.0001). Within the HB group, the
relative risk of not completing secondary education was more than two-fold (RR = 2.49,
95%confidenceinterval1.65–3.73,p < 0.0001)forapersonwithaffected-HBcomparedto
anunaffected-HB.
At the point of school graduation the mean of all school marks (the total average of all
subjects) was significantly different in the three groups F(2,207) = 29.1, p < .0001, the
affected-HB group having the lowest grades and differing from the other two groups in
pair-wisecomparison(p < .0001)(seeFig.2).
The proportion of subjects who by the age of 30 had completed an academic degree
was 11% in the affected-HB group, 32% in the unaffected-HB and 31% in the control
group (p < 0.0001). When other forms of tertiary education (applied universities) were
also included, the relative risk of not completing tertiary education was still elevated
(RR = 1.57, 1.13–2.13, p < 0.004) for a person with affected-HB compared to an
unaffected-HB.
At 30 years of age 86%, 93% and 90% of the groups (affected-HB, unaffected-HB and
controls, respectively) were working or studying full time, showing a similar outcome. At
the other end of the spectrum, however, 11% of the affected-HB, 3% of the controls and
noneoftheunaffected-HBgroupswereunemployed(p < 0.006).
The results indicate that the subgroup of affected-HB had poorer academic achieve-
ment, i.e., lower mean school grades, and less potential to graduate from secondary or
tertiary education. There was also a greater risk for later unemployment. Corresponding
findings in academic and occupational failure are reported in other causes of high birth
risk, e.g., low birth weight and asphyxia (Hack & Klein, 2006; Arpino et al., 2010; Stuart,
Otterblad Olausson & K¨ allen, 2011). The academic achievement is widely regarded as an
objective and a sensitive measure, and it is influenced not only by general intelligence
but also by memory, motivation, executive functions and social skills. A similar course of
underachievement has been found, e.g., in adults with ADHD who may have significantly
less education than expected based on their IQ, and lower occupational levels than
expectedbasedontheireducation(Biedermanetal.,2008).
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 11/20Figure 2 Average school grades at school graduation. The average school grades (mean, SEM, 99%
confidence intervals) of subjects with hyperbilirubinemia and controls.
Social functioning, health and substance use at 30 years of age
Marital status and number of offspring was equal in all groups. Still, social dissatisfaction
score was higher (see Table 3) in the affected-HB group compared to the controls in
pair-wisecomparison(p < 0.002).
The general health problem score was similar in the three groups and there were no
differencesinthereportedincidencesoftraumas,fracturesandconcussions.
Alcohol consumption was more uncontrolled in the affected-HB group compared
to the controls in pair-wise comparison. Particularly, past episodes of driving while
intoxicated were reported by 20% of the affected-HB group but only by 6% and 9% in
the unaffected-HB and control groups respectively. The use of illicit drugs was similar in
thethreegroups,10%ofallreportedhavingusedatanytimeinthepast.
The results indicate higher alcohol consumption in the affected-HB group. Similar
tendencies in association with developmental deficits have also been observed previously
(Biedermanetal.,2008).Excessivealcoholconsumptionmaybeasignificantconfounding
factor in analyzing vocational outcome. The affected-HB group had the highest average in
ascoremeasuringalcoholusebutthenumberofsubjectsreportingconsumptionatalevel
that could be classified as abuse however was small. There were only a few current users of
illicit drugs at the time the questionnaire was completed and the frequency of ever using
any substance was also low. Incidence of substance abuse in Finland has been among the
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 12/20Table3 Resultsfromthequestionnaireat30yearsfortheaffectedandunaffectedgroupswithhyperbilirubinemia(HB)aswellasforthehealthy
controls. The significance for differences between the three groups in univariate comparisons is also given.
Affected-HB
n = 57
Unaffected-HB
n = 71
Controls
n = 70
Mean
(95%CI)
Mean
(95%CI)
Mean
(95%CI)
Univariatetestacross
thethreegroups
Healthandwell-being
Social dissatisfaction score 3.0
(2.5–3.5)
2.3
(1.9–2.8)
1.8
(1.3–2.3)
p < 0.003
General health problems score 2.4
(2.1–2.8)
2.0
(1.7–2.3)
1.8
(1.5–2.2)
ns
Psychiatric problems score 0.2
(0.1–0.3)
0.08
(0.0–0.2)
0.06
(0.0–0.2)
ns
Alcohol consumption score 2.8
(2.0–3.5)
1.4
(0.7–2.1)
1.6
(0.9–2.3)
p < 0.03
Behavioralfunctioning
Current inattention symptoms 2.78
(1.97–3.59)
2.56
(1.88–3.24)
1.91
(1.22–2.60)
ns
Current hyperactive–impulsive symptoms 2.96
(2.12–3.80)
2.86
(2.16–3.56)
2.36
(1.65–3.07)
ns
Childhood inattention symptoms 5.52
(4.34–6.70)
2.79
(1.79–3.78)
2.16
(1.15–3.17)
p < 0.0001
Childhood hyperactive–impulsive symptoms 4.40
(3.26–5.53)
2.68
(1.72–3.63)
2.25
(1.28–3.21)
p < 0.02
Cognitivefunctioning
Subjective persisting problems present absent 13 (23%)
43 (77%)
7 (10%)
64 (90%)
5 (7%)
64 (93%)
p < 0.03
Notes.
CI, Confidence Interval of the mean.
lowest in Europe for decades, although a rise has occurred in the last 10 years (Varjonen et
al., 2012). We conclude that alcohol and substance abuse does not explain the differences
observedinvocationaloutcome.
Cognitive and psychiatric status at 30 years of age
Ongoing cognitive problems, all symptoms combined, were more frequent in the
affected-HB group compared to the two other groups (Table 3). Sixteen per cent of
the affected-HB group reported reading difficulty, 9% writing, 9% speech and 9%
mathematical difficulty, and smaller percentages other learning or perceptual problems.
In the subjective ADHD symptom rating scales (see Table 3) the three groups differed
significantly (MANOVA Wilks’ lambda, p < 0.004). The affected-HB group scored higher
for childhood inattention compared to both the unaffected-HB and the control groups
(p < 0.001), and also higher for childhood hyperactivity/impulsivity compared to the
controls (p < 0.01). The unaffected-HB group scored higher in childhood inattention
compared to the controls (p < 0.002). The difference was not significant for the current
symptomsratingscales.
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 13/20No differences in number of self-reported psychiatric problems between the groups
werefound.Theuseofsedativesorhypnoticswasreportedlysimilarinallgroups.
The results indicate that the various learning disabilities found in a subgroup of the HB
casesinchildhoodcontinueintoadulthood.Inourstudy,23%oftheaffected-HBsubjects
reported persisting cognitive complaints at the age of 30 years, reading difficulties being
reportedmostfrequently.Thisisinlinewiththepreviousresultsat9yearsofage(Helenius,
1987). In addition to learning disabilities, the subjects reported subjective ADHD symp-
toms more frequently than the controls. In the retrospective childhood ADHD symptom
ratingscalebothHBgroups(affectedandunaffected)reportedhigherscoresofinattention
than controls, but the difference was no longer significant in adulthood. The childhood
hyperactive/impulsive symptoms were higher in the affected-HB group, but they too
levelledoffbyadulthood,resemblingthetypicalpatternforADHDsymptoms(Biederman,
Mick & Faraone, 2000; Wilens, Biederman & Spencer, 2002). ADHD is suggested to be
more common among subjects with pre- and perinatal risk factors (Strang-Karlsson et
al., 2008; Gustafsson & K¨ all´ en, 2011; Halmøy et al., 2012) although contradictory findings
have also been reported (Silva, Colvin & Hagemann, 2013). Similarly mixed evidence has
emergedregardingthelinkbetweenADHDandhyperbilirubinemia(Jangaardetal.,2008;
Kuzniewicz, Escobar & Newman, 2009). In our study, the ADHD diagnosis cannot reliably
be made based on questionnaire data, but ADHD symptoms appeared to be a part of the
disabilityspectrum.
CONCLUSIONS
Our aim was to study long term consequences of neonatal hyperbilirubinemia at 30
year-old adults followed up from birth. To exclude the confounding effects of preterm
birth, we included only newborns ≥ 2500 g birth weight and ≥ 37 weeks of gestation.
The subjects with neonatal hyperbilirubinemia were divided into subgroups based on the
presence (affected HB) or absence (unaffected HB) of diagnosed cognitive or behavioral
disabilities in childhood, and compared with healthy controls. Our results indicate that
neonatal HB has negative consequences in adult age. Nearly half of the HB group were
affected by cognitive abnormalities in childhood and continued to experience problems
in adulthood. This was apparent in academic achievement and the ability to complete
secondary and tertiary education. Also, the subgroup of affected HB reported persisting
cognitive complaints, e.g., problems with reading, writing and calculus. Childhood
symptoms of hyperactivity/impulsivity and inattention were more common in HB
groups, but in adulthood the symptom levels were equal. The affected HB still perceived
lower levels of subjective wellbeing as well as social adaptability, and reported more
poorly controlled drinking; findings that may reflect a more profound tendency of poor
adjustment.
The strength of our study is that our control and HB groups were remarkably similar
at birth in terms of medical data and absence of risk factors, other than HB. Our base
cohort’s limit for inclusion in the low birth weight group was 2000 g and inclusion to
any group did not have a fixed limit of weeks of gestation. Consequently, there were a
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 14/20few neonates both in the control and the HB groups, whose gestational age was 35–36
weeks and/or birthweight between 2000 and 2500 g. In order to avoid any further bias we
also excluded these borderline cases. The growth environment of the children was also
very similar in the groups, as the parents’ social status, education, size of family, type of
housing were comparable at birth and at 9 years of age. Further, the children were born
in the same hospital, lived in the same metropolitan area, and attended the same schools.
We also tested for attritional bias, and found none. Therefore we think that confounding
factors are well controlled without need for statistical modeling. Our results should be
well generalizable in otherwise uncomplicated HB cases, even in the era of more modern
therapeuticpossibilities.
A limitation in our study is that a questionnaire is a rather insensitive tool that has
sampling and data processing challenges (Gilbody, House & Sheldon, 2001; Olsen et al.,
2001;Jaddoeetal.,2006;Jaddoeetal.,2010).However,mailedinquiriesarewidelyusedand
allow statistical comparison of parallel groups. Furthermore, in our study the cases had
also been clinically carefully examined from birth up to age 9 years, which increases the
reliability of our data. The main outcomes reported here, i.e., need for remedial teaching,
low school grades and academic underachievement, are objective and we regard the
differences between our groups credible. Still, although statistically significant differences
were found, the results are indicative rather than proof of specific types of cognitive
consequencesduetothelowspecificityofaquestionnaire.
The symptoms we found, e.g., decreased social adjustment, symptoms of the ADHD
spectrum, and the ability to achieve goals when in an instructive environment (primary
education with special tuition) but not when independent planning and execution of
tasks are required (higher education or occupational environment) bear resemblance
to impairment of the fronto-striatal system. The pathogenesis of encephalopathy by
unconjugated bilirubin is poorly understood but it seems to involve oxidative stress,
a disruption of the blood–brain barrier and the consequent damage of neuronal cells
(Palmelaetal.,2011).Brainpathologytypicallyfollowingbilirubinneurotoxicityhasbeen
suggested to involve the basal ganglia, particularly globus pallidus, as well as subthalamic
nuclei, hippocampus, diencephalon, midbrain, pontine and brain stem nuclei and
cerebellum (Johnson & Bhutani, 2011; Koziol, Budding & Chidekel, 2013), locations which
take part in a wide variety of motor, sensory and cognitive functions. Fronto-subcortical
circuits(Cummings,1993)connectthefrontalcortextothebasalgangliaandthesecircuits
participate in executive functions (attention control, response inhibition, planning and
execution). In this respect, HB has common elements with the processes that are active in
otherperinataldisordersthatcausebraindamage,e.g.,ischemia-asphyxiaandimmaturity
and/or low birth weight (e.g., Volpe, 2005; Volpe, 2012). Clearly, speculations on frontal
dysfunction in HB warrant further studies with thorough neuropsychological testing and
neuroimaging.
We conclude that neonatal HB is a recognizable cause of adult age neurobehavioral
problems,severeenoughtohavenegativeoccupationalandqualityoflifeeffects.
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